[Yanzhou Coal Mining Company Limited Date By Zhang Baocai Director YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 1171) List of Directors and their Role and Function Board The members of the sixth session of board of directors (the Li Xiyong Li Wei]
[eFuture Announces Receipt of Preliminary Non-Binding Proposal From Shiji, Its Controlling Shareholder BEIJING, June 06, 2016 (GLOBE NEWSWIRE) -- eFuture Holding Inc. (Nasdaq:EFUT) (the “Company” or “eFuture”), a leading software and solution provider and a mobile business enabler to China's retail and consumer goods industries, today announced receipt of an unsolicited preliminary non-binding proposal to acquire all the remaining outstanding] [Form 6-K 001-33113 eFuture Holding Inc. Room A1103, A1105, A1106-07, Building A, Note: Note: eFuture Holding Inc. Kevin King Chairman 6-K 1 f6k_060616.htm FORM 6-K]
[eFuture Announces Receipt of Preliminary Non-Binding Proposal From Shiji, Its Controlling Shareholder BEIJING, June 06, 2016 (GLOBE NEWSWIRE) -- eFuture Holding Inc. (Nasdaq:EFUT) (the “Company” or “eFuture”), a leading software and solution provider and a mobile business enabler to China's retail and consumer goods industries, today announced receipt of an unsolicited preliminary non-binding proposal to acquire all the remaining outstanding] [Form 6-K 001-33113 eFuture Holding Inc. Room A1103, A1105, A1106-07, Building A, Note: Note: eFuture Holding Inc. Kevin King Chairman 6-K 1 f6k_060616.htm FORM 6-K]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [June 6, 2016 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3 (No. 333-204761) (the “ Common Stock Preferred Stock Prospectus Prospectus Supplement Shares Selling Stockholders Underwriting Agreement We understand that 2,775,000 shares of Common Stock (the “ As legal counsel to] [China Biologic Announces Secondary Offering of Common Stock BEIJING, China – June 2, 2016 The shares to be sold in this offering represent approximately 10.4 percent of the Company’s current outstanding shares of common stock. Morgan Stanley & Co. International plc is acting as the sole underwriter for the offering. prospectus@morganstanley.com This press release shall not constitute an offer to] []
[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [June 6, 2016 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3 (No. 333-204761) (the “ Common Stock Preferred Stock Prospectus Prospectus Supplement Shares Selling Stockholders Underwriting Agreement We understand that 2,775,000 shares of Common Stock (the “ As legal counsel to] [China Biologic Announces Secondary Offering of Common Stock BEIJING, China – June 2, 2016 The shares to be sold in this offering represent approximately 10.4 percent of the Company’s current outstanding shares of common stock. Morgan Stanley & Co. International plc is acting as the sole underwriter for the offering. prospectus@morganstanley.com This press release shall not constitute an offer to] []
[] [I, Bangxin Zhang, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of TAL Education Group; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [Certification by the Principal Financial Officer I, Rong Luo, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of TAL Education Group; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,]
[FANG ANNOUNCES FIRST QUARTER 2016 RESULTS BEIJING, June 2, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ("we," "our," or "Fang"), the leading real estate Internet portal in China, announced today its unaudited financial results for the three months ended March 31, 2016. First Quarter 2016 Highlights · Total Revenue · Operating loss Non-GAAP operating loss · Net loss attributable] []
[FANG ANNOUNCES FIRST QUARTER 2016 RESULTS BEIJING, June 2, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ("we," "our," or "Fang"), the leading real estate Internet portal in China, announced today its unaudited financial results for the three months ended March 31, 2016. First Quarter 2016 Highlights · Total Revenue · Operating loss Non-GAAP operating loss · Net loss attributable] []
